Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Heron Therapeutics (HRTX) stocks in Canada
Learn how to easily invest in Heron Therapeutics stocks.
Heron Therapeutics (HRTX) is a leading biotechnology business based in the US. It opened the day at $14.17 after a previous close of $14.17. During the day the price has varied from a low of $13.83 to a high of $14.17. The latest price was $14.02 (25 minute delay). Heron Therapeutics is listed on the NASDAQ and employs 223 staff. All prices are listed in US Dollars.
How to buy shares in Heron Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HRTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Heron Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Heron Therapeutics?
- Has coronavirus impacted Heron Therapeutics shares?
- Heron Therapeutics shares summary
- Compare share dealing platforms
- Is Heron Therapeutics stock a buy or sell?
- Heron Therapeutics performance over time
- Heron Therapeutics's financials
- How volatile are Heron Therapeutics shares?
- Does Heron Therapeutics pay a dividend?
- Have Heron Therapeutics shares ever split?
- Other common questions
How has Coronavirus impacted Heron Therapeutics's stock price?
Since the stock market crash in March caused by coronavirus, Heron Therapeutics's stock price has had significant negative movement.
Its last market close was $8.14, which is 62.05% down on its pre-crash value of $21.45 and 17.94% down on the lowest point reached during the March crash when the stocks fell as low as $9.6.
If you had bought $1,000 worth of Heron Therapeutics stocks at the start of February 2020, those stocks would have been worth $522.35 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $390.80.
Heron Therapeutics stock price (NASDAQ:HRTX)Use our graph to track the performance of HRTX stocks over time.
Heron Therapeutics shares at a glance
|52-week range||$8.09 - $20.45|
|50-day moving average||$9.76|
|200-day moving average||$12.54|
|Wall St. target price||$31.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.39|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Heron Therapeutics price performance over time
|1 week (2022-01-10)||63.79%|
|1 month (2021-12-17)||45.28%|
|3 months (2021-10-19)||35.72%|
|6 months (2021-07-19)||12.07%|
|1 year (2021-01-19)||-21.89%|
|2 years (2020-01-17)||-34.94%|
|3 years (2019-01-18)||27.03|
|5 years (2017-01-19)||1.23%|
Heron Therapeutics financials
|Revenue TTM||$86.3 million|
|Gross profit TTM||$-120,884,000|
|Return on assets TTM||-37.04%|
|Return on equity TTM||-115.32%|
|Market capitalisation||$886.8 million|
TTM: trailing 12 months
Heron Therapeutics share dividends
We're not expecting Heron Therapeutics to pay a dividend over the next 12 months.
Have Heron Therapeutics's shares ever split?
Heron Therapeutics's shares were split on a 1:20 basis on 13 January 2014. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heron Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Heron Therapeutics shares which in turn could have impacted Heron Therapeutics's share price.
Heron Therapeutics share price volatility
Over the last 12 months, Heron Therapeutics's shares have ranged in value from as little as $8.09 up to $20.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heron Therapeutics's is 1.3401. This would suggest that Heron Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Heron Therapeutics overview
Heron Therapeutics, Inc. , a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A. P.
Stocks similar to Heron Therapeutics
Frequently asked questions
Heron Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.